Ansbert Gadicke - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 1,876,050 shares made by Dirk Kersten , a net purchase of 77,851 shares made by John Cox , and a net sale of 3,102,817 shares made by Jason P Rhodes .

In summary, during the past 3 months, insiders sold 2,172,311 shares of Dyne Therapeutics Inc (DYN) in total and bought 9,000 shares, with a net sale of 2,163,311 shares. During the past 18 months, 5,031,129 shares of Dyne Therapeutics Inc (DYN) were sold and 116,000 shares were bought by its insiders, resulting in a net sale of 4,915,129 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in AlloVir Inc (ALVR). Other recent insider transactions involving AlloVir Inc (ALVR) include a net sale of 303 shares made by Vikas Sinha , a net sale of 106 shares made by Edward Miller , and a net sale of 96 shares made by Brett R Hagen .

In summary, during the past 3 months, insiders sold 0 shares of AlloVir Inc (ALVR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 505 shares of AlloVir Inc (ALVR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 505 shares.

AlloVir Inc (ALVR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made 1 insider transaction in ITeos Therapeutics Inc (ITOS) with a net sale of 1,031,931. Other recent insider transactions involving ITeos Therapeutics Inc (ITOS) include a net sale of 261,412 shares made by Michel Detheux , a net purchase of 4,958,978 shares made by Ecor1 Capital, Llc , and a net sale of 630,191 shares made by Mpm Bioventures 2014, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of ITeos Therapeutics Inc (ITOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,668,407 shares of ITeos Therapeutics Inc (ITOS) were sold and 4,958,978 shares were bought by its insiders, resulting in a net purchase of 2,290,571 shares.

ITeos Therapeutics Inc (ITOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 21,179 shares made by Lloyd Mitchell Segal , a net sale of 6,884 shares made by Steve Forte , and a net sale of 5,611 shares made by Michael Zinda .

In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,270 shares of Repare Therapeutics Inc (RPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,270 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of TCR2 Therapeutics Inc (TCRR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TCR2 Therapeutics Inc (TCRR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TCR2 Therapeutics Inc (TCRR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Harpoon Therapeutics Inc (HARP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harpoon Therapeutics Inc (HARP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Harpoon Therapeutics Inc (HARP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 83,163 shares made by Pamela J. Cramer , a net sale of 62,413 shares made by Joseph Shulman , and a net sale of 119,523 shares made by Hunter C Smith .

In summary, during the past 3 months, insiders sold 41,643 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 41,643 shares. During the past 18 months, 550,753 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 550,753 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Chiasma Inc (CHMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chiasma Inc (CHMA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chiasma Inc (CHMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 236,448 shares made by Michael A Metzger , a net sale of 7,965 shares made by Keith A. Goldan , and a net sale of 53,750 shares made by Botwood Nicholas A.j. .

In summary, during the past 3 months, insiders sold 105,914 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 105,914 shares. During the past 18 months, 367,528 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 26,765 shares were bought by its insiders, resulting in a net sale of 340,763 shares.

Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net sale of 149,158 shares made by Mittie Doyle , a net sale of 98,480 shares made by Christopher Ryan Sullivan , and a net sale of 75,063 shares made by Paul Varki .

In summary, during the past 3 months, insiders sold 10,783 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 10,783 shares. During the past 18 months, 337,235 shares of Avalo Therapeutics Inc (AVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 337,235 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aratana Therapeutics Inc (PETX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aratana Therapeutics Inc (PETX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aratana Therapeutics Inc (PETX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Histogen Inc (HSTOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 62,060 shares made by Shawn Cross , a net sale of 17,109 shares made by Lauren Bullaro Riker , and a net sale of 37,772 shares made by Kristen Marie Williams .

In summary, during the past 3 months, insiders sold 16,374 shares of Pacira BioSciences Inc (PCRX) in total and bought 0 shares, with a net sale of 16,374 shares. During the past 18 months, 131,928 shares of Pacira BioSciences Inc (PCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 131,928 shares.

Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 145,568 shares made by Dan Paterson , a net sale of 24,659 shares made by Daniel Calkins , and a net sale of 2,366 shares made by Brian M Stuglik .

In summary, during the past 3 months, insiders sold 26,262 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 26,262 shares. During the past 18 months, 196,858 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,858 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EPIRUS Biopharmaceuticals Inc (EPRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net purchase of 47,500 shares made by Jerome Benedict Durso , a net purchase of 25,000 shares made by Gregory L Weaver , and a net purchase of 21,700 shares made by John Gill .

In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Altimmune Inc (ALT) were sold and 101,227 shares were bought by its insiders, resulting in a net purchase of 101,227 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Metabasis Therapeutics Inc (LGNZZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metabasis Therapeutics Inc (LGNZZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metabasis Therapeutics Inc (LGNZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Poniard Pharmaceuticals Inc (PARD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poniard Pharmaceuticals Inc (PARD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Poniard Pharmaceuticals Inc (PARD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Affymax Inc (AFFY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Affymax Inc (AFFY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Affymax Inc (AFFY)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Acorda Therapeutics Inc (ACORQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acorda Therapeutics Inc (ACORQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acorda Therapeutics Inc (ACORQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 5,000 shares made by Kamil Ali-jackson , and a net sale of 4,000 shares made by Walter H Moos .

In summary, during the past 3 months, insiders sold 5,000 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 5,000 shares. During the past 18 months, 9,000 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,000 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Bio Green Med Solution Inc (BGMS). Other recent insider transactions involving Bio Green Med Solution Inc (BGMS) include a net sale of 404,505 shares made by Kim Choy Yap , a net sale of 404,465 shares made by Khai Loon Kua , and a net sale of 277,910 shares made by Diversified Berhad Fitters .

In summary, during the past 3 months, insiders sold 0 shares of Bio Green Med Solution Inc (BGMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,309,049 shares of Bio Green Med Solution Inc (BGMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,309,049 shares.

Bio Green Med Solution Inc (BGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 37,659 shares made by Kory James Wentworth , a net sale of 468,474 shares made by 5am Ventures V, L.p. , and a net sale of 468,474 shares made by Kush Parmar .

In summary, during the past 3 months, insiders sold 232,948 shares of Entrada Therapeutics Inc (TRDA) in total and bought 5,000 shares, with a net sale of 227,948 shares. During the past 18 months, 1,030,524 shares of Entrada Therapeutics Inc (TRDA) were sold and 211,911 shares were bought by its insiders, resulting in a net sale of 818,613 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Werewolf Therapeutics Inc (HOWL). Other recent insider transactions involving Werewolf Therapeutics Inc (HOWL) include a net sale of 4,220,911 shares made by Luke Evnin , a net sale of 1,938,945 shares made by Mpm Oncology Innovations Fund Lp , and a net sale of 1,641,479 shares made by Mpm Bioventures 2014, L.p. .

In summary, during the past 3 months, insiders sold 3,687,889 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 3,687,889 shares. During the past 18 months, 9,910,475 shares of Werewolf Therapeutics Inc (HOWL) were sold and 536,426 shares were bought by its insiders, resulting in a net sale of 9,374,049 shares.

Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 58,433 shares made by Jennifer Michaelson , a net sale of 52,347 shares made by Nadim Ahmed , and a net sale of 19,091 shares made by Jeffrey Alan Jones .

In summary, during the past 3 months, insiders sold 8,000 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 8,000 shares. During the past 18 months, 148,848 shares of Cullinan Therapeutics Inc (CGEM) were sold and 1,874,057 shares were bought by its insiders, resulting in a net purchase of 1,725,209 shares.

Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made no insider transaction in Kalaris Therapeutics Inc (KLRS). Other recent insider transactions involving Kalaris Therapeutics Inc (KLRS) include a net purchase of 724,147 shares made by Srinivas Akkaraju , and a net sale of 2,822 shares made by Brett R Hagen .

In summary, during the past 3 months, insiders sold 0 shares of Kalaris Therapeutics Inc (KLRS) in total and bought 244,300 shares, with a net purchase of 244,300 shares. During the past 18 months, 2,822 shares of Kalaris Therapeutics Inc (KLRS) were sold and 724,147 shares were bought by its insiders, resulting in a net purchase of 721,325 shares.

Kalaris Therapeutics Inc (KLRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Ansbert Gadicke made 1 insider transaction in Aktis Oncology Inc (AKTS) with a net purchase of 1,112,777. Other recent insider transactions involving Aktis Oncology Inc (AKTS) include a net sale of 7,921 shares made by Ken Herrmann , a net purchase of 2,222,222 shares made by Ecor1 Capital, Llc , and a net purchase of 1,112,777 shares made by Mpm Bioventures 2018, L.p. .

In summary, during the past 3 months, insiders sold 107,921 shares of Aktis Oncology Inc (AKTS) in total and bought 0 shares, with a net sale of 107,921 shares. During the past 18 months, 107,921 shares of Aktis Oncology Inc (AKTS) were sold and 6,350,646 shares were bought by its insiders, resulting in a net purchase of 6,242,725 shares.

Aktis Oncology Inc (AKTS)'s detailed insider trading history can be found in Insider Trading Tracker table.